About the Authors
- Jamie D. Weyandt
-
Affiliation Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, North Carolina, United States of America
- John M. Carney
-
Affiliation Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America
- Elizabeth N. Pavlisko
-
Affiliation Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America
- MengMeng Xu
-
Affiliation Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, North Carolina, United States of America
- Christopher M. Counter
-
* E-mail: count004@mc.duke.edu
Affiliations Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, North Carolina, United States of America, Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceptualization: JDW CMC. Formal analysis: JDW JMC ENP MX. Funding acquisition: CMC. Investigation: JDW JMC ENP MX. Methodology: JDW. Supervision: CMC ENP. Validation: MX. Visualization: JDW JMC ENP MX CMC. Writing – original draft: JDW JMC ENP CMC. Writing – review & editing: JDW JMC ENP MX CMC.